SearchCME LoginCE Login Show Cart
NACE: National Association For Continuing Education 866-266-6223 9a am to 5 pm EST Mon-Fri
CME Course Description

   
Login to view
Course Activities.

CME Live Virtual Conferences

Go Back


National Association For Continuing Education


Course Directors
Gregg Sherman, MD
Chief Medical Officer, NACE
Plantation, FL

Deborah Paschal, CRNP
Clinical Nurse Practitioner
Cardiothoracic Surgery Division
Penn-Presbyterian Medical Center
Philadelphia, PA

Medical Writer
Josh Kilbridge
Kilbride Associates Healthcare Communications
San Francisco, CA

Faculty
Brad P. Glick, DO, MPH, FAOCD, FAAD
Program Director, Dermatology Residency
Larkin Community Hospital - Palm Springs Campus
Assistant Clinical Professor of Dermatology
Herbert Wertheim College of Medicine
Miami, FL

Kristine Kucera, PA-C, MPAS, DHS
Associate Clinical Professor
Physician Assitant Studies
University of Texas Southwestern Medical Center
Dallas, TX

Paul S. Yamauchi, MD, PhD
Medical Director, Dermatology Institute and Skin Care Center
Clinical Assistant Professor of Dermatology, David Geffen School of Medicine at UCLA
Adjunct Associate Professor, John Wayne Cancer Institute
Santa Monica, CA

Title
: The Inflammatory State of Psoriasis: New and Emerging Therapies
Activity/Course #:
: NCME327
Cost:
: Free
Release/Start Date:
: Feb 14 2017
Expiration Date:
: Feb 13 2018
Topics:
: Dermatology
Target Audience:
: Primary Care Providers
Format:
: Monograph
Estimated Time To Complete CME Activity:
: 1.0 Hour
Credit(s):
: 1.0 AMA PRA Category I Credit(s)
1.0 AANP Contact hour(s) which includes 0.25 pharmacology hour(s)
Hardware/Software Requirements:
(Chrome not supported at this time)
Psoriasis is a common and debilitating disease that initially presents to primary care. Many clinicians are familiar with the typical dermatologic lesions of psoriasis, but may not realize that the impact of the disease extend far deeper than the skin. The inflammatory state underlying psoriasis likely contributes to increased risk for multiple serious comorbidities, including psoriatic arthritis, metabolic syndrome, cardiovascular disease, and lymphoma, among others. Patients with psoriasis report significant deficits in their quality of life, including their ability to work and engage in social relationships, Worse yet, psoriasis is associated with increased risk for mortality.

The good news is that effective treatment can dramatically improve psoriatic skin and joint disease. This monograph reviews the presentation, evaluation, and management of psoriasis – and its many comorbidities – with a focus on the role of primary care clinicians.

Learning Objective(s):

After completing this program participants should be able to:

  1. Recognize the clinical presentation and current immunopathophysiology of psoriasis and psoriatic arthritis.
  2. Identify and discuss the significance of the ever-expanding numbers of co-morbid conditions and emerging biofactors associated with psoriatic disease.
  3. Discuss current therapeutic protocols for psoriasis and its related disorders .
  4. Interpret latest evidence-based data on emerging treatment options for psoriatic disease.

How To Obtain Your CME Certificate

  1. Register for the course at www.naceonline.com.
  2. View the content.
  3. Complete and submit the post-test and evaluation.
  4. A minimum passing score of 80% must be earned on the post-test in order to complete the CME activity.
  5. Print your CME certificate.
Sponsored and Certified By
National Association for Continuing Education
Accreditation Designation Statement
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.

National Association for Continuing Education is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners. AANP Provider Number 121222. This program has been approved for 1.0 contact hour of continuing education(which includes 0.25 pharmacology hours).
Faculty Disclosure Policy
Policy on Faculty and Provider Disclosure: It is the policy of the National Association for Continuing Education to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the National Association for Continuing Education are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosures are provided below.

Brad P. Glick, DO, MPH, FAOCD, FAAD, Faculty, serves on the speakers bureau for SunPharma/Ranbaxy, Merz, LEO, Abbvie, Janssen, Celgene, Galderma, Lilly, and Novartis Pharmaceuticals Corporation. Dr. Glick is also a member of the advisory board for Lilly and a TopMD stockholder.

Kristine Kucera, PA-C, MPAS, DHS, Faculty, is a speaker for AbbVie, Celgene, Janssen, Novartis Pharmaceuticals Corporation, Promius, Leo and Valeant. She is a consultant for Anacor, Encore, and Eli Lilly.

Paul S. Yamauchi, MD, PhD, Faculty, serves as a consultant for AbbVie, Amgen, Celgene Corporation, Janssen-Ortho Inc., LEO Pharma, US, Novartis Pharmaceuticals Corporation, Pfizer Inc., and Regeneron. He serves as a speaker for AbbVie, Amgen, Celgene Corporation, Galderma USA, Janssen-Ortho Inc., LEO Pharma Inc., and Novartis Pharmaceuticals Corporation. Dr. Yamauchi is also a principal investigator for Amgen, Celgene Corporation, Dermira, Galderma USA, Janssen-Ortho Inc., LEO Pharma Inc., Lilly ICOS LLC, Medimmune, Novartis Pharmaceuticals Corporation, Pfizer Inc., Regeneron, and Sandoz, a Novartis company. He also serves on the advisory boards of Amgen, Dermira, and Lilly ICOS LLC.

Gregg Sherman, MD, Co-Course Director, has no relationships to disclose.

Deborah Paschal, CRNP, Co-Course Director, has no relationships to disclose.

Josh Kilbridge, Medical Writer, has no relationships to disclose.

Harvey C. Parker, Ph.D., Activity Planning Committee, has no relationships to disclose.

Michelle Frisch, MPH, Activity Planning Committee, has no relationships to disclose.

Alan Goodstat, LCSW, Activity Planning Committee, has no relationships to disclose.

Cheryl C. Kay, Activity Planning Committee, has no relationships to disclose.
Commercial Support
This activity is supported by educational grant from Novartis Pharmaceuticals Corporation.